Sigma-Tau公司宣布兒童VSL#3益生菌登陸美國

    October 16, 2012 —Sigma-Tau Pharmaceuticals, Inc., announced today the U.S. launch of VSL#3® JUNIOR, a once-a-day, high-potency probiotic medical food for the dietary management of children who suffer from irritable bowel syndrome (IBS) and ulcerative colitis (UC). Unlike other marketed probiotics, VSL#3® JUNIOR is presently the only probiotic sold as a medical food for IBS and UC. Refrigerated VSL#3® JUNIOR contains 8 proprietary strains of 225 billion live bacteria, making it approximately 50 times more potent than the average probiotic.
    2012年10月16日，Sigma-Tau公司宣布兒童VSL#3益生菌登陸美國。該產(chǎn)品是用于患有腸易激綜合征、潰瘍性結(jié)腸炎兒童的膳食管理的保健食品。與其他益生菌不同，VSL#3益生菌是目前唯一一個(gè)作為治療腸易激綜合征和潰瘍性結(jié)腸炎的保健食品。凍干的VSL#3益生菌含有8大類2250億株活菌，效果是普通益生菌的50倍。（信息來源：Sigma-Tau公司官網(wǎng)）